标题:The Medicinal Potential of Influenza Virus Surface Proteins: Hemagglutinin and Neuraminidase
作者:Xie, Y.; Gong, J.; Li, M.; Fang, H.; Xu, W.
作者机构:[Xie, Y.; Gong, J.; Li, M.; Fang, H.; Xu, W.] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Shandong, Peoples R China.
通讯作者:Xu, W
通讯作者地址:[Xu, W]Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Shandong, Peoples R China.
来源:CURRENT MEDICINAL CHEMISTRY
出版年:2011
卷:18
期:7
页码:1050-1066
DOI:10.2174/092986711794940815
关键词:Antibody; antigenic shift; hemagglutinin; influenza; inhibitor; membrane; fusion; neuraminidase; receptor specificity
摘要:Nowadays, influenza virus is still a big threat to human. Hemagglutinin (HA) and neuraminidase (NA) are the two viral surface proteins, which play important roles in the life cycle of influenza virus. Current influenza vaccines and anti-influenza drugs work mainly by interfering with the functions of the two proteins. In this review, we will display some recent studies about the two proteins. As to HA, this review covers a lot including its fusion function, receptor specificity, antigenic shift hypothesis, novel antibodies and various inhibitors in order to deeply discuss this protein. As to NA, this review mainly focuses on studies about the newly identified 150-cavity of group-1 NAs and shows some untypical NA inhibitors aiming to provide a broader range of lead compounds for anti-influenza drug design.
收录类别:SCOPUS;SCIE
WOS核心被引频次:15
Scopus被引频次:16
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952801722&doi=10.2174%2f092986711794940815&partnerID=40&md5=efb0eb12b1075618a6645eb3120635d0
TOP